US Stock MarketDetailed Quotes

TGTX TG Therapeutics

Watchlist

29.340
+0.130+0.45%

Close Feb 26 16:00 ET

29.100
-0.240-0.82%

Post 20:01 ET

4.57BMarket Cap-293.40P/E (TTM)

TG Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TG Therapeutics Q4 2024 Estimates Date

Currency：USDMar 3, 2025

	Estimate	YoY
Revenue	100.67M	+128.95%
EPS	0.09	+187.69%

Analyst Rating

Buy

Feb 25, 2025

TG Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 116.457M	--
Mar 3, 2025	2024/Q4	-- / 100.674M	--
Nov 4, 2024	2024/Q3	83.879M / 81.705M	--
Aug 6, 2024	2024/Q2	73.466M / 65.893M	--
May 1, 2024	2024/Q1	63.474M / 54.608M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 116.457M--

Mar 3, 20252024/Q4-- / 100.674M--

Nov 4, 20242024/Q383.879M / 81.705M--

Aug 6, 20242024/Q273.466M / 65.893M--

May 1, 20242024/Q163.474M / 54.608M--

Unlock Free Earnings Estimates

Open Account

TG Therapeutics Earnings Reports

TG Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:38 ET

TG Therapeutics | 8-K: ® TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance